Diagnostics, Science & Technology
Day: Thursday | Time: 13:45 - 15:15
Session Coordinators:
Julie Staves & Yvonne Scott
Speakers:
How immunogenic is RhD positive transfusions to RhD negative patients
Prof. Mark Yazer, University of Pittsburgh
Monoclonal antibodies and the problems with provision of safe red cells
Dr Mark Williams, NHSBT Filton
Presentation Unavailable
Oral Presentations:
RHCE*Ce329C: a novel RHCE allele associated with a weakened C antigen expression and genetically linked to RHD*DVII allele
Cedric Vrignaud
1345_thu_boisdale1_vrignau.pdf
Julie Staves
Intended Audience:
BMS, Medical Staff
Learning Objectives: TBC
Brief Description:
This session will look at issues associated with red cell antibodies and the impact of them on the provision of red cells. The sensitisation with anti-D in RHD negative patients is an important issue as it increases the amount of O RhD negative red cells we use as a service. The use of monoclonal antibodies as a treatment for haematological malignancies is increasing, the problems associated to their use and how we provide safe red cell transfusions.
Session Tags:
